Streetbeat News

Price Targets

EVH

Evolent Health shares are trading higher following better-than-expected Q2 financial results. Truist Securities upgraded the stock from Hold to Buy and raised its price target from $28 to $33.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:57 am

APLS

Goldman Sachs analyst Salveen Richter maintains a Buy rating on Apellis Pharmaceuticals (NASDAQ:APLS) and raises the price target from $66 to $74.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:57 am

RXRX

Needham analyst Gil Blum maintains a Buy rating on Recursion Pharmaceuticals (NASDAQ:RXRX) but lowers the price target from $17 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:57 am

QNST

Craig-Hallum analyst Jason Kreyer maintains a Buy rating on QuinStreet (NASDAQ:QNST) and raises the price target from $22 to $25.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:56 am

AKAM

Craig-Hallum analyst Jeff Van Rhee has upgraded Akamai Technologies (NASDAQ:AKAM) from Hold to Buy and raised the price target from $110 to $125.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:54 am

TTGT

Needham analyst Joshua Reilly has reiterated a Buy rating on TechTarget (NASDAQ:TTGT) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:54 am

GILD

BMO Capital analyst Evan Seigerman maintains an Outperform rating on Gilead Sciences (NASDAQ:GILD) and raises the price target from $80 to $85.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:53 am

DXC

BMO Capital analyst Keith Bachman maintains a Market Perform rating on DXC Technology (NYSE:DXC) and raises the price target from $17.5 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:52 am

TTD

The Trade Desk shares are trading higher following better-than-expected Q2 financial results and strong Q3 revenue guidance. Keybanc and Susquehanna have also raised their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:51 am

PAY

Baird analyst David Koning maintains an Outperform rating on Paymentus Holdings (NYSE:PAY) and raises the price target from $23 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:51 am